Neuronetics (STIM) Non-Current Debt (2017 - 2026)
Neuronetics' (STIM) quarterly Non-Current Debt came in at $61.3 million in Q1 2026, up 10.76% year-on-year from $55.3 million in Q1 2025, and down 6.85% on a QoQ basis from $65.8 million in Q4 2025.
Neuronetics (STIM) Non-Current Debt (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Non-Current Debt data on file, last reported at $61.3 million in Q1 2026.
- On a quarterly basis, Non-Current Debt rose 10.76% year-over-year to $61.3 million in Q1 2026; TTM through Mar 2026 was $61.3 million, a 10.76% increase from a year earlier, with the FY2025 full-year figure at $65.8 million, up 19.32% from the prior year.
- Non-Current Debt for Q1 2026 stood at $61.3 million, down from $65.8 million in the prior quarter.
- Over the last five years, Non-Current Debt for STIM reached as high as $65.8 million in Q4 2025 and fell as low as $22.8 million in Q4 2022.
- Historically, Non-Current Debt has averaged $46.8 million across 5 years, with a median of $46.1 million in 2024.
- Across the five-year window, Non-Current Debt slumped 35.39% in 2022 and soared 159.68% in 2023, its largest moves.
- Year by year, Non-Current Debt stood at $22.8 million in 2022, then surged by 159.68% to $59.3 million in 2023, then fell by 6.97% to $55.2 million in 2024, then advanced by 19.32% to $65.8 million in 2025, then decreased by 6.85% to $61.3 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $61.3 million in Q1 2026, $65.8 million in Q4 2025, and $65.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | 10.13 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 3.18 Bn |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 8.07 Bn |
| 10 | Neuronetics | 119.69 Mn | 113.69 Mn | 16.15 Mn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.30 Mn |
| Dec 31, 2025 | 65.81 Mn |
| Sep 30, 2025 | 65.67 Mn |
| Jun 30, 2025 | 55.54 Mn |
| Mar 31, 2025 | 55.34 Mn |
| Dec 31, 2024 | 55.15 Mn |
| Sep 30, 2024 | 46.00 Mn |
| Jun 30, 2024 | 46.15 Mn |
| Mar 31, 2024 | 59.44 Mn |
| Dec 31, 2023 | 59.28 Mn |
| Sep 30, 2023 | 36.85 Mn |
| Jun 30, 2023 | 36.71 Mn |
| Mar 31, 2023 | 36.64 Mn |
| Dec 31, 2022 | 22.83 Mn |
| Sep 30, 2022 | 27.01 Mn |
| Jun 30, 2022 | 31.21 Mn |
| Mar 31, 2022 | 35.44 Mn |
| Dec 31, 2021 | 35.34 Mn |
| Jun 30, 2021 | 34.94 Mn |
| Mar 31, 2021 | 34.79 Mn |